Phase I clinical trial group finds efficiencies, increases

Opening any clinical trial requires the satisfaction of many regulatory requirements for very good reasons. Scores of people review applications, confer in committees, weigh risks and benefits, all to make sure that the investigator has patient safety as their guide. This process is important, but it can also be lengthy and overlong delays can doom a trial before it can even […]

Clinical trials in cancer at Iowa barely lose a step

Last week, the American Society of Clinical Oncology (ASCO) released a special report titled “A Guide to Cancer Care Delivery During the COVID-19 Pandemic.” It details an approach for oncologists and other care providers to ensure their own safety and that of those they treat, given the higher likelihood of a patient’s immuno-compromised status.  For […]

New Clinical Trials in Internal Medicine

Obtaining approval for a clinical trial is no easy feat. A combination of scientific vision, managerial skill, and an awareness of the responsibility owed both to the research as well as to the patients being treated is needed. We offer our congratulations to these researchers on their success in securing support for their upcoming clinical […]